Table 2. Clinical outcome measures before and after treatment.
| Variables | Experimental group | Control group | ||
|---|---|---|---|---|
| Before | After | Before | After | |
| FMA-LLparetic | 25.4 ± 7.5 | 27.4 ± 6.7* | 22.9 ± 7.9 | 25.9 ± 4.8* |
| BBS | 36.3 ± 11.7 | 46.7 ± 9.4** | 39.0 ± 8.7 | 49.8 ± 4.6** |
| 6MWT (m) | 167.5 ± 121.8 | 261.0 ± 115.4** | 157.5 ± 64.0 | 276.0 ± 69.8** |
| K-MBI | 65.7 ± 23.3 | 87.0 ± 10.5** | 57.4 ± 22.4 | 85.3 ± 13.7** |
Values are mean ± standard deviation. FMA-LLparetic: paretic lower limb score of the Fugl-Meyer assessment; BBS: Berg balance test; 6MWT: 6-minute walk test; K-MBI: Korean version of the Modified Barthel Index
* p<0.05, ** p<0.01